top of page
Research Articles






Ramakrishna Pai Jakribettu; Surlu Vidya Rao; Jessica Chavali; Jaffey Mary Mathew; Indu Parkavi; Manjeshwar Shrinath Baliga


ABSTRACT: Background: In recent years, bacterial infections have become a major problem and worse in immunocompromised cancer patients. The objective of this study was to observe for drug resistance pattern in bacteria isolated in infections of Skin and soft tissue in Cancer Patients (SSTI). Methods: This is a retrospective study and was carried out checking in to the medical records for 3 years (January 2009 to December 2011). The incidence and drug resistance pattern for various clinically used antibiotics against the isolated bacteria were analyzed. Results: A total of 395 cases of organisms were isolated. The gram negative bacteria accounted for 59.45% of the total culture positives. Methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli were the most common gram positive and negative bacteria respectively. The isolates were resistant to most antibiotics with highest resistant being seen in the MRSA and the Multidrug resistant coagulase-negative staphylococci (MRCONS). However all isolates were sensitive to the new generation antibiotics Linezolid, Tigecycline, Daptomycin and Vancomycin. Conclusions: The study demonstrated that the bacteria studied had different resistance to most of the standard antibiotics. However all Gram negative organisms studied were sensitive to colistin, and Gram positive were sensitive to vancomycin, linezolid and teicoplanin

KEY WORDS: Cancer; Skin and soft tissue infections; Methicillin-resistant Staphylococcus aureus (MRSA) and Multidrug Resistant Coagulase-Negative Staphylococci (MRCONS)


  1. Zembower TR (2014). Epidemiology of Infections in Cancer Patients. In: Infectious Complications in Cancer Patients, Cancer Treatment and Research. Eds: V. Stosor and T. R. Zembower, Springer International Publishing, Switzerland. pp 43-89.

  2. Donnelly JP, Blijlevens NMA, De Pauw BE (2009) Infections in the immunocompromised host: general principles. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, USA.pp 3781–3792.

  3. Saghir S, Faiz M, Saleem M, Younus A, Aziz H. Characterization and anti-microbial susceptibility of gram negative bacteria  isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan. Ind J Med Microbiol (2009) 27(4): 341-7

  4. .Pizzo A, Meyers J, Freifeld AG and Walsh T. (2009). “Infection in the cancer patient,” in Cancer Principle and Practice of  Oncology, V. T. DeVita, S. Hellman, and S. Rosenberg, Eds., pp. 2292–2337, Lippincot Company, Philadelphia, Pa, USA, 8th  edition, 2009.

  5. .Kofteridis DP, Valachis A, Koutsounaki E, Maraki S, Mavrogeni E, Economidou FN, Dimopoulou D, Kalbakis K, Georgoulias V, Samonis G. Skin and soft tissue infections in patients with solid tumours. Scientific World Journal. 2012; 2012:804518. doi:  10.1100/2012/804518.

  6. Wilker M A CFR, Bush K, Dudley M N, et al., The Performance of Standards for Antimicrobial Disk Suspectibility Tests: Approved Standard. Clinical and Laboratory Standards Institute.2009; 29(1):11-12.

  7. Prabhash K, Medhekar A, Ghadyalpatil N, Noronha V, Biswas S, Kurkure P, et al. Blood stream infections in cancer patients: A single center experience of isolates and sensitivity pattern. Indian J Cancer 2010;47:184-188.

  8. Butt T, Afzal RK, Ahmad RN, Salman M, Mahmood A, Anwar M. Bloodstream infections in febrile neutropenic patients: Bacterial spectrum and antimicrobial susceptibility pattern. J Ayub Med Coll Abbottabad 2004; 16: 18-22.

  9. Chen CY, Tang JL, Hsueh PR, Yao M, Huang SY, Chen YC, et al. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. J Formos Med Assoc 2004; 103: 526-532.

  10. Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Gonçalves VM. Bloodstream infection surveillance in a cancer centre: A prospective look at clinical microbiology aspects. ClinMicrobiol Infect 2004; 10: 542-549.

  11. Kapoor G, Sachdeva N, Jain S. Epidemiology of bacterial isolates among pediatric cancer patients from a tertiary care oncology center in North India. Indian J Cancer 2014;51:420-4.

  12. Al Hasan MN, Huskins WC, Lahr BD, EckelPassow JE, Baddour LM. Epidemiology and outcome of Gram negative bloodstream infection in children: A population based study. Epidemiol Infect 2011;139:791‑6.

  13. Levy I, Leibovici L, Drucker M, Samra Z, Konisberger H, Ashkenazi S. A prospective study of Gram negative bacteremia in children.Pediatr Infect Dis J 1996; 15:117-22.

  14. Laupland KB, Gregson DB, Vanderkooi OG, Ross T, Kellner JD. The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006.Pediatr Infect Dis J 2009; 28:114-7

  15. Sankarankutty J, Kaup S. Distribution and Antibiogram of Gram Negative Isolates from Various Clinical Samples at a Teaching Hospital, Tumkur. Sch. J. App. Med. Sci., 2014; 2(3A):927-931

  16. Bhat V, Gupta S, Kelkar R, Biswas S, Khattry N, Moiyadi A, et al. Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center. Indian J Med PaediatrOncol 2016;37:20-4

  17. Singh R, Jain S, Chabbra R, Naithani R, Upadhyay A, Walia M. Characterization and anti-microbial susceptibility of bacterial isolates: Experience from a tertiary care cancer center in Delhi. Indian J Cancer 2014; 51: 477-80.

  18. Kloos WE, Bannerman TL 1994. Update on clinical significance of coagulase-negative staphylococci. ClinMicrobiol Rev 7: 117-140.

bottom of page